Bruker Corporation (BRKR) Income Statement
BRKR 2025 at a glance
Fiscal year ended December 31, 2025 · U.S. dollarsBRKR revenue and net income
Where BRKR's revenue goes
2025Each bar shows an amount and its share of revenue. BRKR kept −0.3% of revenue as net income.
BRKR profit margins
BRKR growth rates
to 2025| 1 year | 3 years | 5 years | 10 years | |
|---|---|---|---|---|
| Revenue | +2.1% | +10.7% | +11.6% | +7.8% |
| Gross profit | −4.4% | +6.5% | +10.9% | +8.3% |
| Operating income | −6.8% | −18.3% | −1.0% | +4.9% |
| Net income | −107.6% | — | — | — |
| EPS (diluted) | −24.1% | −7.9% | +6.3% | +7.4% |
1-year change and average annual growth (CAGR) over 3, 5 and 10 fiscal years. "—" when a starting value was zero or negative.
BRKR quarterly EPS vs estimates
Bruker beat the analyst EPS estimate in 6 of the last 8 quarters. Next report: November 2, 2026 (estimate $0.42).
BRKR income statement
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $3.44B | $3.37B | $2.96B | $2.53B | $2.42B | $1.99B | $2.07B | $1.90B | $1.77B | $1.61B |
| Cost of revenue | $1.86B | $1.72B | $1.45B | $1.23B | $1.21B | $1.05B | $1.08B | $995.6M | $952.9M | $868.8M |
| Gross profit | $1.58B | $1.65B | $1.51B | $1.31B | $1.21B | $939.8M | $995.3M | $900.0M | $813.0M | $742.5M |
| Research & development | $395.2M | $376.5M | $294.8M | $235.9M | $220.8M | $198.0M | $187.7M | $173.4M | $162.7M | $149.0M |
| Sales, general & admin | $946.5M | $893.8M | $730.6M | $612.2M | $565.6M | $487.0M | $504.8M | $444.7M | $415.9M | $390.5M |
| Total operating expenses | $1.34B | $1.40B | $1.08B | $873.0M | $796.3M | $691.5M | $694.4M | $618.1M | $578.6M | $539.5M |
| Operating income | $236.0M | $253.1M | $436.9M | $432.7M | $413.3M | $248.3M | $300.9M | $262.4M | $214.7M | $177.2M |
| Interest income | $14.8M | $9.3M | $7.7M | $4.1M | $900,000 | $3.2M | $1.3M | $1.2M | $800,000 | $300,000 |
| Interest expense | $60.3M | $47.9M | $16.4M | $16.1M | $14.3M | $14.4M | $16.0M | $12.6M | $15.4M | $13.2M |
| Income before taxes | $21.0M | $205.2M | $546.2M | $414.9M | $393.6M | $225.8M | $280.4M | $244.7M | $197.8M | $177.6M |
| Income taxes | $29.3M | $91.4M | $117.7M | $116.4M | $113.0M | $64.4M | $82.4M | $63.7M | $117.5M | $23.1M |
| Net income | −$8.6M | $113.1M | $427.2M | $296.6M | $277.1M | $157.8M | $197.2M | $179.7M | $78.6M | $153.6M |
| EBITDA | $302.6M | $438.6M | $675.5M | $518.7M | $497.0M | $320.7M | $372.0M | $340.1M | $299.5M | $262.1M |
| EPS (diluted) | $1.83 | $2.41 | $2.58 | $2.34 | $2.10 | $1.35 | $1.57 | $1.40 | $1.22 | $1.19 |
| Gross margin | 45.9% | 49.0% | 51.0% | 51.6% | 50.0% | 47.3% | 48.0% | 47.5% | 46.0% | 46.1% |
| Operating margin | 6.9% | 7.5% | 14.7% | 17.1% | 17.1% | 12.5% | 14.5% | 13.8% | 12.2% | 11.0% |
| Net margin | −0.3% | 3.4% | 14.4% | 11.7% | 11.5% | 7.9% | 9.5% | 9.5% | 4.5% | 9.5% |
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Jun '25 | Mar '25 | Dec '24 | Sep '24 | Jun '24 | Mar '24 | Dec '23 | Sep '23 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $838.5M | $823.4M | $977.2M | $860.5M | $797.4M | $801.4M | $979.6M | $864.4M | $800.7M | $721.7M | $854.5M | $742.8M |
| Cost of revenue | $422.5M | $434.1M | $528.0M | $481.1M | $439.5M | $410.2M | $486.3M | $445.6M | $416.1M | $368.9M | $424.2M | $360.0M |
| Gross profit | $416.0M | $389.3M | $449.2M | $379.4M | $357.9M | $391.2M | $493.3M | $418.8M | $384.6M | $352.8M | $430.3M | $382.8M |
| Research & development | $94.3M | $101.3M | $99.6M | $98.3M | $100.2M | $97.1M | $104.4M | $98.1M | $92.2M | $81.8M | $83.5M | $71.3M |
| Sales, general & admin | $238.9M | $242.1M | $247.2M | $242.5M | $225.4M | $225.4M | $244.8M | $247.5M | $221.6M | $195.6M | $211.8M | $177.8M |
| Total operating expenses | $481.3M | $344.3M | $337.4M | $344.4M | $346.0M | $359.4M | $421.2M | $350.7M | $336.5M | $288.0M | $326.8M | $258.3M |
| Operating income | −$65.3M | $45.0M | $111.8M | $35.0M | $11.9M | $31.8M | $72.1M | $68.1M | $48.1M | $64.8M | $103.5M | $124.5M |
| Interest income | $15.3M | $7.9M | $4.6M | $4.4M | $2.9M | $3.1M | $2.4M | $1.9M | $2.4M | $2.6M | $5.9M | $2.0M |
| Interest expense | $17.8M | $12.2M | $11.2M | $20.3M | $15.7M | $13.1M | $15.6M | $11.6M | $15.7M | $5.0M | $4.4M | $3.9M |
| Income before taxes | −$40.7M | $18.2M | $67.0M | −$72.6M | $1.1M | $25.5M | $54.6M | $55.1M | $23.7M | $71.8M | $241.7M | $119.5M |
| Income taxes | $14.2M | $2.5M | $37.8M | −$14.1M | −$3.1M | $8.7M | $40.7M | $14.8M | $16.1M | $19.8M | $37.1M | $30.8M |
| Net income | −$52.0M | $14.4M | $26.0M | −$59.6M | $7.6M | $17.4M | $13.7M | $40.9M | $7.6M | $50.9M | $205.5M | $88.1M |
| EBITDA | $17.3M | $88.7M | $137.5M | $4.2M | $72.3M | $88.6M | $124.6M | $117.9M | $84.8M | $111.3M | $282.6M | $149.7M |
| EPS (diluted) | $0.49 | $0.31 | $0.59 | $0.45 | $0.32 | $0.47 | $0.76 | $0.60 | $0.52 | $0.53 | $0.70 | $0.74 |
| Gross margin | 49.6% | 47.3% | 46.0% | 44.1% | 44.9% | 48.8% | 50.4% | 48.4% | 48.0% | 48.9% | 50.4% | 51.5% |
| Operating margin | −7.8% | 5.5% | 11.4% | 4.1% | 1.5% | 4.0% | 7.4% | 7.9% | 6.0% | 9.0% | 12.1% | 16.8% |
| Net margin | −6.2% | 1.7% | 2.7% | −6.9% | 1.0% | 2.2% | 1.4% | 4.7% | 0.9% | 7.1% | 24.0% | 11.9% |
Quarterly columns are labeled by the month the quarter ended. Figures in U.S. dollars as reported in BRKR's financial statements (latest annual report filed February 27, 2026); data from EODHD. Sales, general & administrative expenses include sales and marketing.
BRKR financial results
In fiscal year 2025 (ended December 31, 2025), Bruker reported revenue of $3.4 billion, up 2.1% from the year before. It had a net loss of $8.6 million, a net profit margin of −0.3%. Diluted earnings per share came to $1.83. Over five years revenue grew at an average rate of 11.6% a year.
See the BRKR stock overview for the latest quote and news, or the BRKR chart for price history and technical indicators.
BRKR income statement FAQ
What is Bruker's annual revenue?
Bruker reported total revenue of $3.4 billion for fiscal year 2025, which ended on December 31, 2025. That was up 2.1% from $3.4 billion the previous year.
Is Bruker profitable?
No. Bruker reported a net loss of $8.6 million in fiscal 2025, a net profit margin of −0.3%; its operating margin was 6.9%.
What is Bruker's gross margin?
Bruker's gross margin was 45.9% in fiscal 2025: for every $100 of revenue, Bruker kept $46 after the direct cost of its products and services.
How much does Bruker spend on research and development?
Bruker spent $395.2 million on research and development in fiscal 2025, 11.5% of revenue.
How fast is Bruker growing?
Revenue grew 11.6% a year on average over the last five fiscal years, from $2.0 billion to $3.4 billion.
What are Bruker's earnings per share?
Bruker earned $1.83 per diluted share in fiscal 2025, compared with $2.41 a year earlier.
When will Bruker report its next earnings?
Bruker is expected to report results for the quarter ending September 30, 2026 on November 2, 2026.
When does Bruker's fiscal year end?
Bruker's fiscal year ends in December. The latest annual report covers the year ended December 31, 2025 and was filed on February 27, 2026.